Posted 4th March 2020 by Liv Sewell
Marcel Kuntz is a panellist for the panel discussion on the regulatory landscape for plant biotechnology at the 8th Plant Genomics & Gene Editing Congress: Europe. Here he provides us with some background for the discussion.
Posted 10th January 2020 by Liv Sewell
Growing and selling genetically modified organisms (GMOs) is permitted in the UK but GMO products are subject to a lengthy and stringent EU authorization process. There are currently no GM crops grown commercially in the UK, but they are imported. So, what is the UK’s relationship with GM products, and where do we stand on gene editing? We spoke with Nigel Halford, Principal Research Scientist at Rothamsted Research, UK.
Posted 2nd September 2019 by Joshua Sewell
The latest event in the Plant Genomics series provided two days of intriguing topics and case studies, not least concerning the ECJ ruling on gene editing and Machine Learning techniques in plant genomics. We have made the following presentation slides available from Ian Bancroft, Anna Coll, Aalt-Jan van Dijk, Nigel Halford, and Jurriaan Ton.
Posted 20th August 2018 by Jane Williams
Degrading soil quality and increased interest in sustainable farming have caused the biostimulant market to go from strength-to-strength and it is expected to reach $4.14 billion by 2025.  Despite this, companies have expressed concerns that the regulation of biostimulants will hinder industry growth and the longevity of small companies and start-ups.
We spoke to Nick Moon, Global Regulatory Manager, Plant Impact, to discuss the regulation of biostimulants and its impact on industry.
Posted 13th June 2018 by Jane Williams
We were delighted to welcome Richard Visser, Professor, Chair and Head of Plant Breeding, Dean of Research, Wageningen University & Research, to the 6th Plant Genomics and Gene Editing Congress, where he presented on the use of novel breeding techniques in practical breeding.
Posted 8th June 2018 by Jane Williams
Aurélie Bayle is a Data Protection Officer at be-ys: a role she considers to be at the heart of the new legal framework for any company.
Before GDPR came into effect on 25th May 2018, she was working towards global compliance, which involved completing all the steps given by the Article 29 Data Protection Working Party, an advisory board made up of a representative from the data authority of each EU Member State, the European Data Protection Supervisor, and the European Commission. Her duties have included auditing the structures and processes, preparing the data protection impact assessments, checking the compliance of processing activities, analysing the risks of the processing in the medical area, preparing new processes and policies about data protection, and asking data processors about their own compliance.